ANIP insider trading
Open-market stock trades by ANI Pharmaceuticals (ANIP) executives and directors: who bought or sold, how many shares, at what price and when.
ANIP insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $72.87 | $207.68K |
| Oct 15, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 5,400 | $71.89 | $388.21K |
| Oct 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $73.59 | $36.80K |
| Sep 29, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $73.00 | $208.05K |
| Sep 15, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 5,400 | $71.00 | $383.40K |
| Sep 11, 2026 | Thoma Jeanne | director | Sell | 1,000 | $71.53 | $71.53K |
| Sep 14, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $70.79 | $35.40K |
| Aug 31, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $72.80 | $207.48K |
| Aug 25, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 5,400 | $74.30 | $401.22K |
| Aug 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $75.48 | $37.74K |
| Aug 10, 2026 | Gutwerg Ori | SVP, GENERICS | Sell | 3,162 | $77.00 | $243.47K |
| Jul 29, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $81.36 | $231.88K |
| Jul 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $81.84 | $40.92K |
| Jul 2, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,313 | $86.00 | $284.92K |
| Jun 29, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $84.12 | $239.74K |
| Jun 12, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $82.03 | $41.02K |
| Jun 8, 2026 | HAUGHEY THOMAS | director | Sell | 2,000 | $80.88 | $161.76K |
| Jun 5, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,312 | $80.00 | $264.96K |
| May 11, 2026 | Walsh Patrick D | director | Sell | 3,973 | $80.75 | $320.82K |
| May 13, 2026 | Walsh Patrick D | director | Sell | 10,000 | $80.63 | $806.30K |
| May 12, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Sell | 459 | $79.21 | $36.36K |
| May 11, 2026 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 55,000 | $77.57 | $4.27M |
| May 12, 2026 | Gutwerg Ori | SVP, GENERICS | Sell | 2,772 | $79.50 | $220.37K |
| May 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $78.16 | $39.08K |
| Apr 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $77.95 | $38.98K |
| Mar 11, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Sell | 4,772 | $74.91 | $357.47K |
| Mar 13, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,162 | $71.64 | $226.53K |
| Mar 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $72.62 | $36.31K |
| Mar 6, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 2,121 | $74.22 | $157.42K |
| Mar 9, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,602 | $74.18 | $267.20K |
| Mar 6, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,485 | $75.00 | $111.38K |
| Mar 9, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 5,087 | $74.13 | $377.10K |
| Mar 5, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,312 | $75.42 | $249.79K |
| Mar 5, 2026 | CAREY STEPHEN P. | SVP & CFO | Sell | 4,000 | $75.56 | $302.24K |
| Mar 2, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 417 | $74.00 | $30.86K |
| Mar 3, 2026 | Gutwerg Ori | SVP, GENERICS | Sell | 2,060 | $76.50 | $157.59K |
| Mar 3, 2026 | Walsh Patrick D | director | Sell | 6,000 | $74.23 | $445.38K |
| Feb 20, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 5,323 | $78.02 | $415.30K |
| Feb 19, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 2,084 | $77.53 | $161.57K |
| Feb 20, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | Sell | 1,730 | $77.99 | $134.92K |
- ANIP insiders bought $0.00 and sold $12.65M in open-market trades over their last 40 filings.
Updated 2026-11-02 23:12 UTC